VAERS Explorer
Back to explore

Report #2891039

Received Mar 27, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
Age unknown
State
NY
Recovered
Recovered
Vaccinated
Onset
Days to onset
Hospital days

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
MENBMENINGOCOCCAL B (TRUMENBA)PFIZER\WYETHUNK

Symptoms (3)

ErythemaPainSwelling

Symptom narrative

pain, redness, and swelling that remained for 3 days following the injection .; pain, redness, and swelling that remained for 3 days following the injection .; pain, redness, and swelling that remained for 3 days following the injection .; This is a spontaneous report received from a Physician from a sales representative. An adolescent male patient received meningococcal group b Rlp2086 (TRUMENBA), as dose number unknown, single (Batch/Lot number: unknown) for immunisation. It was unknown if the patient received any other vaccines on the same date as the suspect vaccine. It was unknown if the patient received any other vaccines within 4 weeks PRIOR to the suspect vaccine. It was unknown if the patient was taking any other medications within 2 weeks of the event starting. The patient's relevant medical history included: "allergy" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: PAIN (non-serious), ERYTHEMA (non-serious), SWELLING (non-serious), outcome "recovered" and all described as "pain, redness, and swelling that remained for 3 days following the injection .". Therapeutic measures were not taken as a result of pain, erythema, swelling. The information on the batch/lot number for meningococcal group b Rlp2086 will be requested and submitted if and when received.

Medical history

Medical History/Concurrent Conditions: Allergy